Osong Public Health and Research Perspectives10.1016/j.phrp.2014.06.002201454187-192The Recency Period for Estimation of Human Immunodeficiency Virus Incidence by the AxSYM Avidity Assay and BED-Capture Enzyme Immunoassay in the Republic of KoreaHye-Kyung Yu, Tae-Young Heo, Na-Young Kim, Jin-Sook Wang, Jae-Kyeong Lee, Sung Soon Kim, Mee-Kyung Kee,
The Brazilian Journal of Infectious Diseases10.1016/j.bjid.2014.03.0012014184449-453Comparison among the BED capture enzyme immunoassay test and AxSYM avidity index assay for determining recent HIV infection and incidence in two Voluntary Counselling and Testing Centres in Northeast BrazilDaniela Medeiros Salustiano, Kledoaldo Oliveira de Lima, Ana Maria Salustiano Cavalcanti, Ricardo Sobhie Diaz, Heloisa Ramos Lacerda,
Journal of Clinical Microbiology10.1128/jcm.42.6.2623-2628.200420044262623-2628Performance Characteristics of the Immunoglobulin G-Capture BED-Enzyme Immunoassay, an Assay To Detect Recent Human Immunodeficiency Virus Type 1 SeroconversionTrudy Dobbs, Susan Kennedy, Chou-Pong Pau, J. Steven McDougal, Bharat S. Parekh,
PLOS ONE10.1371/journal.pone.01523272016114e0152327Mean Recency Period for Estimation of HIV-1 Incidence with the BED-Capture EIA and Bio-Rad Avidity in Persons Diagnosed in the United States with Subtype BDebra L. Hanson, Ruiguang Song, Silvina Masciotra, Angela Hernandez, Trudy L. Dobbs, Bharat S. Parekh, S. Michele Owen, Timothy A. Green
Osong Public Health and Research Perspectives10.1016/j.phrp.2015.06.002201563184-191Modification of AxSYM Human Immunodeficiency Virus Assay to Identify Recent Human Immunodeficiency Virus Infections in Korean Human Immunodeficiency Virus-Positive IndividualsJin-Sook Wang, Mee-Kyung Kee, Byeong-Sun Choi, Sung Soon Kim,
PLoS ONE10.1371/journal.pone.00132592010510e13259Pregnancy Does Not Affect HIV Incidence Test Results Obtained Using the BED Capture Enzyme Immunoassay or an Antibody Avidity AssayOliver Laeyendecker, Jessica D. Church, Amy E. Oliver, Anthony Mwatha, S. Michele Owen, Deborah Donnell, Ron Brookmeyer, Philippa Musoke, J. Brooks Jackson, Laura Guay, Clemesia Nakabiito, Thomas C. Quinn, Susan H. Eshleman
PLoS ONE10.1371/journal.pone.0098038201496e98038Improved Testing of Recent HIV-1 Infections with the BioRad Avidity Assay Compared to the Limiting Antigen Avidity Assay and BED Capture Enzyme Immunoassay: Evaluation Using Reference Sample Panels from the German Seroconverter CohortAndrea Hauser, Claudia Santos-Hoevener, Karolin Meixenberger, Ruth Zimmermann, Sybille Somogyi, Stefan Fiedler, Alexandra Hofmann, Barbara Bartmeyer, Klaus Jansen, Osamah Hamouda, Norbert Bannert, Claudia Kuecherer
Transfusion10.1046/j.1537-2995.1997.37997454018.x1997379921-925Use of human immunodeficiency virus (HIV) type 1 and 2 recombinant strip immunoblot assay to resolve enzyme immunoassay anti-HIV-2- repeatably reactive samples after anti-HIV-1/2 combination enzyme immunoassay screeningLH Tobler, E Kaufman, N Gefter, C Schable, MP Busch,
Journal of Virological Methods10.1016/s0166-0934(96)02122-21997631-2137-143Detection of human immunodeficiency virus type 1 and type 2 antibodies by a new automated microparticle immunoassay AxSYM HIV-1/HIV-2Bernard Weber, Natascha Behrens, Hans Wilhelm Doerr,
Open Forum Infectious Diseases10.1093/ofid/ofw172.46720163suppl_1OraQuick ADVANCE Rapid Human Immunodeficiency Virus (HIV)-1/2 Antibody Test Comparability to Automated Enzyme Immunoassay (EIA)Graham Yearwood